Search inquiry: <.>II=ЕУ12/2017/39/1<.> |
Total number of found documents : 29
Shown documents from 1 till 20 |
|
>1.
| Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population/M. Nikbakht [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.57-64
|
>2.
| Alternative direction of inhibition of malignant properties in tumor cells in vitro and in vivo by gene therapy with INF-beta gene in recombinant baculovirus vector/O. Lykhova [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.90
|
>3.
| Anti-histone H1 IgGs prossess proliferative activity towards human T-leukemia CEM cells/Yu. Kit [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.36-41
|
>4.
| Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing Ehrlich solid carcinoma/T. V. Symchych [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.42-48
|
>5.
| Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics/V. F. Chekhun [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.25-29
|
>6.
| Biological characteristics of tumor cells at the different stages of EMT upon exposure to anticancer drugs and cytokines/N. Bezdieniezhnych [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.89-90
|
>7.
| CD150/SLAMF1 antigen in molecular pathobiology of chronic lymphocytic leukemia/I. Gordiienko [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.91-92
|
>8.
| CD150/SLAMF1 as a new potential target for anti-tumor therapy/S. P. Sidorenko [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.90-91
|
>9.
| Borikun T. Changes in expression of miRNA-122, -200b, and -320a as prognostic biomarkers for breast cancer/T. Borikun, N. Lukianova, V. Chekhun // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.92
|
>10.
| Circulating tumor cells in breast cancer/N. V. Cherdyntseva [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.2-11
|
>11.
| Diagnostic challenges with intraoral myeloid sarcoma/P. Kumar [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.78-85
|
>12.
| Kashuba E. Do MRPS 18-2 and RB proteins cooperate to control cell stemness and differentiation, preventing cancer development?/E. Kashuba, M. Mushtag // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.12-16
|
>13.
| Effect of antitumor drugs in low concentrations on the biological, immunophenotypic and cytogenetic characteristics of human colon cancer cells in vitro/N. Bezdieniezhnych [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.17-24
|
>14.
| Endoplasmic reticulum stress as a key factor of genome reprogramming in cancer cells/O. O. Ratushna [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.88-89
|
>15.
| EPR spectroscopy studies of changes in erythrocyte membranes in patients with laryngeal cancer/Y. B. Burlaka [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.49-52
|
>16.
| Brieieva O. Genotoxic sensitivity to 4-hydroxyestradiol in peripheral blood lymphocytes of endometrial cancer patients/O. Brieieva, I. Nesina, L. Buchynska // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.93
|
>17.
| High expression levels of MRPS 18-2 and presence of the RB protein are required for the maintenance of stem cell phenotype/M. Mushtag [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.92-93
|
>18.
| Mankovska O. Identification of novel molecular and genetic markers for early detection and prognosis of epithelial tumors/O. Mankovska, V. Kashuba // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.93
|
>19.
| Satinder K. Impact of single nucleotide polymorphism in chemical metabolizing genes and exposure to wood smoke on risk of cervical cancer in North-Indian women/K. Satinder, R. C. Sobti, K. Pushpinder // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.69-74
|
>20.
| International scientific conference "Normal and and cancer stem cells: discovery, diagnosis and therapy", October 5-6, 2017, Kyiv, Ukraine // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.95
|
|
|